GB1036059A - Improvements in or relating to the inhibition of bacterial growth - Google Patents

Improvements in or relating to the inhibition of bacterial growth

Info

Publication number
GB1036059A
GB1036059A GB10139/65A GB1013965A GB1036059A GB 1036059 A GB1036059 A GB 1036059A GB 10139/65 A GB10139/65 A GB 10139/65A GB 1013965 A GB1013965 A GB 1013965A GB 1036059 A GB1036059 A GB 1036059A
Authority
GB
United Kingdom
Prior art keywords
inhibition
relating
bacterial growth
composition
cycloserine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB10139/65A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commercial Solvents Corp
Original Assignee
Commercial Solvents Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commercial Solvents Corp filed Critical Commercial Solvents Corp
Publication of GB1036059A publication Critical patent/GB1036059A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bacterial infections are inhibited by the oral administration of a composition comprising cycloserine and O-carbamyl-D-serine. The composition may be administered in conventional oral dosage unit forms.
GB10139/65A 1964-12-10 1965-03-10 Improvements in or relating to the inhibition of bacterial growth Expired GB1036059A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41749464A 1964-12-10 1964-12-10

Publications (1)

Publication Number Publication Date
GB1036059A true GB1036059A (en) 1966-07-13

Family

ID=23654247

Family Applications (1)

Application Number Title Priority Date Filing Date
GB10139/65A Expired GB1036059A (en) 1964-12-10 1965-03-10 Improvements in or relating to the inhibition of bacterial growth

Country Status (4)

Country Link
BE (1) BE661838A (en)
FR (1) FR4909M (en)
GB (1) GB1036059A (en)
IL (1) IL22934A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517099A (en) * 1968-06-10 1970-06-23 Commercial Solvents Corp Production of a cycloserine-o-carbamyl-d-serine composition
US3505449A (en) * 1968-06-10 1970-04-07 Commercial Solvents Corp Production of a cycloserine-o-carbamyl-d-serine composition

Also Published As

Publication number Publication date
BE661838A (en) 1965-07-16
IL22934A (en) 1968-11-27
FR4909M (en) 1965-03-13

Similar Documents

Publication Publication Date Title
CA969474A (en) Rumen stable medicament and/or nutrient compositions
AU461863B2 (en) Propanolamine derivatives, their preparation and therapeutic compositions containing thesame
ZA71221B (en) New pharmaceutical compositions for the treatment of microbial infections
GB1036059A (en) Improvements in or relating to the inhibition of bacterial growth
ES368325A1 (en) Cephalosporius having a thioltherified methyl group in the 3-position
IE36780L (en) Pharmaceutical preparations
FR1456M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
CA957280A (en) Progestational composition in oral dosage form
GB976096A (en) Pharmaceutical compositions
AU414340B2 (en) Medicinal compositions for administration to animals and process for administering same
CA724631A (en) Therapeutic compositions for oral administration
AU3469468A (en) Medicinal compositions for administration to animals and process for administering same
AU460683B2 (en) New pharmaceutical compositions for the treatment of microbial infections
FR1510M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
AU433463B2 (en) Improvements in or relating to proteinic pharmaceutical compositions for use inthe treatment of obesity
GB1065938A (en) Hydrazine compound and preparation thereof
GB1036055A (en) Pharmaceutical compositions comprising d-serine
AU2425571A (en) New pharmaceutical compositions for the treatment of microbial infections
CA879658A (en) Compositions containing a benzoxazolone derivative for the treatment or prevention of parasitic infections in domestic animals
GB1072263A (en) Therapeutic compositions for use in the treatment of the common cold
AU3485568A (en) Improvements in or relating to proteinic pharmaceutical compositions for use inthe treatment of obesity
CA747349A (en) Medicament pour les affections des muqueuses
AU771866A (en) Improvements relating to the administration of medicaments and the like
AU271945B2 (en) Therapeutic composition and dosage units thereof
AU416181B2 (en) Improvements in or relating to medicament injector